Perimenopause library

Treatment literacy

Articles in this section

• What NAMS currently says about hormone and nonhormone options

  NAMS 2022 describes hormone therapy as the most effective treatment for bothersome vasomotor symptoms and genitourinary syndrome, with a timing window. NAMS 2023 lists nonhormone options with evidence grades. This is guideline language, not a prescription.